Hamid D Davoudi

US Patent:

8360065, Jan 29, 2013

Filed:

May 19, 2010

Appl. No.:

12/782958

Inventors:

Michael S. H. Chu - Brookline MA, US
Jianmin Li - Lexington MA, US
Hamid Davoudi - Westwood MA, US

Assignee:

Boston Scientific Scimed, Inc. - Maple Grove MN

International Classification:

A61F 6/06
A61F 13/00
A61B 19/00
A61M 1/00
A61M 5/178
A61M 29/00

US Classification:

128831, 128830, 128832, 128833, 128839, 604 28, 604 36, 604108, 604158, 424422, 424430

Abstract:

According to one claim of the invention, a method for occluding a fallopian tube in a vertebrate subject is described, which comprises comprising transcervically delivering a solid blocking material into the fallopian tube. In various embodiments, a fluid sealing material is delivered along with the solid blocking material. Other claims of the invention pertain to articles of manufacture, delivery devices and kits for use in occluding the fallopian tubes of a vertebrate subject.

US Patent:

8414656, Apr 9, 2013

Filed:

Sep 25, 2009

Appl. No.:

12/567367

Inventors:

Hamid Davoudi - Westwood MA, US
Alfred Intoccia - Nashua NH, US
Jianmin Li - Lexington MA, US

Assignee:

Boston Scientific Scimed, Inc. - Maple Grove MN

International Classification:

A61F 2/04

US Classification:

623 237

Abstract:

In some embodiments, a stent includes an elongate member and a distal retention member. The elongate member is configured to be disposed within a ureter of a patient and has a first portion, a second portion and a plurality of beads bonded together. The plurality of beads define a plurality of spaces between the plurality of beads. The plurality of spaces are configured to allow fluid to flow from the first portion of the elongate member to the second portion of the elongate member. The distal retention member is configured to help maintain a portion of the stent within a kidney of the patient.

US Patent:

8512272, Aug 20, 2013

Filed:

Dec 10, 2009

Appl. No.:

12/635345

Inventors:

Isaac Ostrovsky - Wellesley MA, US
Jozef Slanda - Milford MA, US
Jianmin Li - Lexington MA, US
Hamid Davoudi - Westwood MA, US
Robert T. Miragliuolo - Chelmsford MA, US

Assignee:

Boston Scientific Scimed, Inc. - Maple Grove MN

International Classification:

A61M 5/00
A61F 2/04

US Classification:

604 8, 604 9

Abstract:

In some embodiments, a ureteral stent includes an elongate member having a first portion and a second portion, which is coupled to the first portion. The first portion of the elongate member is configured to be disposed within a kidney of a patient. The second portion of the elongate member, which has a sidewall that defines a lumen, is configured to deliver fluid from a first location of the sidewall of the second portion to a second location of the sidewall of the second portion via capillary action. The second portion of the elongate member is configured to be disposed within at least one of a bladder and a ureter of the patient.

US Patent:

8545386, Oct 1, 2013

Filed:

Feb 23, 2006

Appl. No.:

11/360460

Inventors:

Jianmin Li - Lexington MA, US
Michael Madden - Princeton MA, US
Hamid Davoudi - Westwood MA, US

Assignee:

Boston Scientific Scimed, Inc. - Maple Grove MN

International Classification:

A61F 2/02

US Classification:

600 30

Abstract:

The invention relates generally to surgical implants, and in various embodiments to surgical implants configured for promoting growth of collagenous tissue at an anatomical site.

US Patent:

20030224033, Dec 4, 2003

Filed:

Feb 28, 2003

Appl. No.:

10/377131

Inventors:

Jianmin Li - Lexington MA, US
Danielle Conley - Waltham MA, US
Weenna Couto - Winchester MA, US
Cang Dao - Attleboro MA, US
Hamid Davoudi - Westwood MA, US
Raymond Lareau - Westford MA, US
Kathleen Miller - Shrewsbury MA, US

International Classification:

A61F002/00
A61M025/098

US Classification:

424/423000, 604/529000

Abstract:

Implantable or insertable medical devices are provided, which comprises: (a) a biocompatible polymer; and (b) at least one therapeutic agent selected from an anti-inflammatory agent, an analgesic agent, an anesthetic agent, and an antispasmodic agent. The medical devices are adapted for implantation or insertion at a site associated with pain or discomfort upon implantation or insertion. In many embodiments, the therapeutic will be selected from at least one of (i) ketorolac and pharmaceutically acceptable salts thereof (e.g., ketorolac tromethamine) and (ii) 4-diethylamino-2-butynylphenylcyclohexyl glycolate and pharmaceutically acceptable salts thereof (e.g., oxybutynin chloride). Also provided are uses for the implantable or insertable medical devices, which uses comprise reducing pain or discomfort accompanying the implantation or insertion of such devices. Further uses may comprise reducing microbial buildup along the device. Methods for manufacturing implantable or insertable medical devices are also provided.

US Patent:

20090171143, Jul 2, 2009

Filed:

Dec 22, 2008

Appl. No.:

12/341701

Inventors:

Michael S. H. Chu - Brookline MA, US
Hamid Davoudi - Westwood MA, US
Ty Fairneny - Hopkinton MA, US
James Goddard - Pepperell MA, US
Roger P. Goldberg - Evanston IL, US
Jianmin Li - Lexington MA, US
Steven A. Olivieri - Shrewsbury MA, US
John Petricca - Ashland MA, US
Jozef Slanda - Milford MA, US
Ken Toso - Westborough MA, US
Michael Weiser - Groton MA, US

International Classification:

A61F 2/02

US Classification:

600 37

Abstract:

In one embodiment, a method includes securing an implant that includes a pre-formed loop to a vaginal apex. An end of the suture is inserted through a selected portion of a pelvic tissue to dispose at least a portion of the implant within a pelvic region of the patient. The end of the suture is drawn through the loop while simultaneously advancing a uterus to approximate the vaginal apex to the selected portion of pelvic tissue. An apparatus includes an implant and a suture coupled to the implant having a pre-formed loop. configured to receive a portion of a delivery device therethrough. A trocar is coupled to an end of the suture that can be releasably coupled to an end of the delivery device. The trocar can be inserted through a pelvic tissue and drawn through the loop forming a knot to secure the implant to the pelvic tissue.

US Patent:

20090287245, Nov 19, 2009

Filed:

Feb 27, 2009

Appl. No.:

12/394965

Inventors:

Isaac Ostrovsky - Wellesley MA, US
Hamid Davoudi - Westwood MA, US
Jianmin (Jamie) Li - Lexington MA, US
Jozef Slanda - Milford MA, US

International Classification:

A61B 17/04
A61B 17/08

US Classification:

606228, 606151

Abstract:

In one embodiment, a medical device includes an elongate member configured to be inserted into a body. The elongate member has a first end portion and a second end portion opposite the first end portion. The elongate member includes a retaining member extending from the elongate member. The retaining member is configured to anchor the elongate member with respect to bodily tissue. The first end portion of the elongate member includes a coupling portion configured to be coupled to a filament. The second end portion of the elongate member includes a coupling portion configured to be coupled to the filament.

US Patent:

20120150096, Jun 14, 2012

Filed:

Feb 24, 2012

Appl. No.:

13/404832

Inventors:

Jianmin LI - Lexington MA, US
Danielle Conley - Waltham MA, US
Weenna Bucay-Couto - Burlington MA, US
Cang Duy Dao - Attleboro MA, US
Hamid Davoudi - Westwood MA, US
Raymond J. Lareau - Westford MA, US
Kathleen M Miller - Shrewsbury MA, US

Assignee:

BOSTON SCIENTIFIC SCIMED, INC. - Maple Grove MN

International Classification:

A61M 5/00
A61P 29/00
A61K 31/56
A61K 9/00

US Classification:

604 8, 424486, 424487, 514169

Abstract:

Implantable or insertable medical devices are provided, which comprises: (a) a biocompatible polymer; and (b) at least one therapeutic agent selected from an anti-inflammatory agent, an analgesic agent, an anesthetic agent, and an antispasmodic agent. The medical devices are adapted for implantation or insertion at a site associated with pain or discomfort upon implantation or insertion. In many embodiments, the therapeutic will be selected from at least one of (i) ketorolac and pharmaceutically acceptable salts thereof (e.g., ketorolac tromethamine) and (ii) 4-diethylamino-2-butynylphenylcyclohexyl glycolate and pharmaceutically acceptable salts thereof (e.g., oxybutynin chloride). Also provided are uses for the implantable or insertable medical devices, which uses comprise reducing pain or discomfort accompanying the implantation or insertion of such devices. Further uses may comprise reducing microbial buildup along the device. Methods for manufacturing implantable or insertable medical devices are also provided.